EC Number | Cloned (Comment) | Organism |
---|---|---|
2.1.1.212 | expression in Escherichia coli | Medicago truncatula |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.150 | Medicago truncatula | - |
- |
- |
2.1.1.150 | Medicago truncatula | Q06YR3 | - |
- |
2.1.1.150 | Medicago truncatula | Q06YR4 | - |
- |
2.1.1.212 | Medicago truncatula | Q29U70 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.1.1.212 | - |
Medicago truncatula |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.150 | additional information | no activity with 6,7-dihydroxy-4'-methoxyisoflavone | Medicago truncatula | ? | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 5,7,4'-trihydroxyisoflavone | i.e. genistein. 49% of the activity with 7,4'-dihydroxy-6-methoxyisoflavone (i.e. glycitein) | Medicago truncatula | S-adenosyl-L-homocysteine + 5,4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 5,7,4'-trihydroxyisoflavone | i.e. genistein. 61% of the activity with 7,4'-dihydroxyisoflavone (i.e. daidzein) | Medicago truncatula | S-adenosyl-L-homocysteine + 5,4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 6,7,4'-trihydroxyisoflavone | preferred substrate | Medicago truncatula | S-adenosyl-L-homocysteine + 6,4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 6,7,4'-trihydroxyisoflavone | 35% of the activity with 7,4'-dihydroxyisoflavone (i.e. daidzein) | Medicago truncatula | S-adenosyl-L-homocysteine + 6,4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 6,7,4'-trihydroxyisoflavone | 44% of the activity with 7,4'-dihydroxy-6-methoxyisoflavone (i.e. glycitein) | Medicago truncatula | S-adenosyl-L-homocysteine + 6,4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,3',4'-trihydroxyisoflavone | 41% of the activity with 7,4'-dihydroxy-6-methoxyisoflavone (i.e. glycitein) | Medicago truncatula | S-adenosyl-L-homocysteine + 3',4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,3',4'-trihydroxyisoflavone | 43% of the activity with 7,4'-dihydroxyisoflavone (i.e. daidzein) | Medicago truncatula | S-adenosyl-L-homocysteine + 3',4'-dihydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxy-6-methoxyisoflavone | i.e. glycitein, 39% of the activity with 7,4'-dihydroxyisoflavone (i.e. daidzein) | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-6,7-dimethoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxy-6-methoxyisoflavone | i.e. glycitein, 52% the activity with 6,7,4'-trihydroxyisoflavone (i.e. daidzein) | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-6,7-dimethoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxy-6-methoxyisoflavone | i.e. glycitein, preferred substrate | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-6,7-dimethoxyisoflavone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxyisoflavanone | i.e. dihydrodaidzein. 15.6% of the activity with 7,4'-dihydroxy-6-methoxyisoflavone (i.e. glycitein) | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-7-methoxyisoflavanone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxyisoflavanone | i.e. dihydrodaidzein. 70% of the activity with 7,4'-dihydroxy-6-methoxyisoflavone (i.e. glycitein) | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-7-methoxyisoflavanone | - |
? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxyisoflavone | i.e. daidzein. 21% of the activity with 7,4'-dihydroxy-6-methoxyisoflavone (i.e. glycitein) | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-7-methoxyisoflavone | i.e. formononetin | ? | |
2.1.1.150 | S-adenosyl-L-methionine + 7,4'-dihydroxyisoflavone | i.e. daidzein. Preferred substrate | Medicago truncatula | S-adenosyl-L-homocysteine + 4'-hydroxy-7-methoxyisoflavone | - |
? | |
2.1.1.212 | additional information | low activity with dihydrodaidzein. 4'-Methoxy, 7-methoxy, and 4',7-dimethoxy products are formed in the reaction with dihydrodaidzein. No activity with: 6,7,4'-trihydroxyisoflavone, 6,7'-dihydroxy,4'-methoxyisoflavone, 7,3',4'-trihydroxyisoflavone, daidzein, genistein, glycitein, coumestrol, apigenin, 7,4'-dihydroxyflavone and myricetin | Medicago truncatula | ? | - |
? | |
2.1.1.212 | S-adenosyl-L-methionine + 2,7,4'-trihydroxyisoflavanone | - |
Medicago truncatula | S-adenosyl-L-homocysteine + 2,7-dihydroxy-4'-methoxyisoflavanone | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.150 | MtIOMT1 | - |
Medicago truncatula |
2.1.1.150 | MtIOMT2 | - |
Medicago truncatula |
2.1.1.150 | MtIOMT3 | - |
Medicago truncatula |
2.1.1.212 | MtIOMT5 | - |
Medicago truncatula |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.1.1.212 | 30 | - |
assay at | Medicago truncatula |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.1.1.212 | 7.4 | - |
assay at | Medicago truncatula |